Metraipolis › archive › dc_d8237dcd5c23

Antibody-Empowered Nanomedicine for Precise Biomedical Applications — Europe PMC PMID:41524227

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41524227
DOI
10.1002/advs.202521428
License (as archived)
solo-consultazione
Archived
2026-11-06T21:57:15.558Z
SHA-256 of the archived text
5dc6c11d73b2fbccb091213931f48fc8a5eac2cb34c20b2a45006f0db539f26d
Stable URL of this page
https://metraipolis.com/documento/dc_d8237dcd5c23

How to cite

Antibody-Empowered Nanomedicine for Precise Biomedical Applications — Europe PMC PMID:41524227 — Europe PMC (en), https://europepmc.org/article/MED/41524227 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d8237dcd5c23 (Metraipolis archive dc_d8237dcd5c23, sha256 5dc6c11d73b2fbccb091213931f48fc8a5eac2cb34c20b2a45006f0db539f26d)
BibTeX
@misc{dcd8237dcd5c23,
  title = {Antibody-Empowered Nanomedicine for Precise Biomedical Applications — Europe PMC PMID:41524227},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41524227},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d8237dcd5c23; sha256 5dc6c11d73b2fbccb091213931f48fc8a5eac2cb34c20b2a45006f0db539f26d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41524227. Agents can read the archived copy with the MCP tool read_document.